The development of focal segmental glomerulosclerosis secondary to anabolic steroid abuse
- PMID: 22669525
- PMCID: PMC3233923
- DOI: 10.1136/bcr.07.2011.4531
The development of focal segmental glomerulosclerosis secondary to anabolic steroid abuse
Abstract
The authors present the case of a patient who presented to the nephrology department of a district general hospital with end-stage renal failure. He presented with malignant hypertension and symptoms and signs of uraemia. He also gave a history of prior abuse of anabolic steroids over a number of years. Renal biopsy was performed and the findings were in keeping with a diagnosis of advanced focal segmental glomerulosclerosis (FSGS). The patient went on to require renal replacement therapy within weeks of presentation. The authors suggest that anabolic steroid abuse is a direct cause of FSGS. People with raised body mass index are known to be at increased risk of developing this condition, due to increased haemodynamic stress on the glomeruli, with subsequent development of sclerosis. However, the authors believe that anabolic steroid abuse may be an independent risk factor, and that anabolic steroids have a direct nephrotoxic effect that leads to a more advanced initial presentation with rapid decline in renal function.
Conflict of interest statement
Similar articles
-
Development of focal segmental glomerulosclerosis after anabolic steroid abuse.J Am Soc Nephrol. 2010 Jan;21(1):163-72. doi: 10.1681/ASN.2009040450. Epub 2009 Nov 16. J Am Soc Nephrol. 2010. PMID: 19917783 Free PMC article.
-
[Collapsing Glomerulopathy Secondary to Anabolic Steroids for Bodybuilding: A Case Series].G Ital Nefrol. 2023 Oct 26;40(5):2023-vol5. G Ital Nefrol. 2023. PMID: 38010246 Italian.
-
[FSGS collapsing variant during anabolic steroid abuse: Case Report].G Ital Nefrol. 2018 Dec;35(6):2018-vol6. G Ital Nefrol. 2018. PMID: 30550036 Italian.
-
Severe laryngitis following chronic anabolic steroid abuse.J Laryngol Otol. 2008 Mar;122(3):230-2. doi: 10.1017/S0022215107007542. Epub 2007 May 14. J Laryngol Otol. 2008. PMID: 17498324 Review.
-
ACOG Committee Opinion No. 484: Performance enhancing anabolic steroid abuse in women.Obstet Gynecol. 2011 Apr;117(4):1016-1018. doi: 10.1097/AOG.0b013e3182192281. Obstet Gynecol. 2011. PMID: 21422881 Review.
Cited by
-
Anabolic-androgenic steroids: How do they work and what are the risks?Front Endocrinol (Lausanne). 2022 Dec 19;13:1059473. doi: 10.3389/fendo.2022.1059473. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36644692 Free PMC article. Review.
-
Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research.Front Pharmacol. 2022 Aug 8;13:932739. doi: 10.3389/fphar.2022.932739. eCollection 2022. Front Pharmacol. 2022. PMID: 36003509 Free PMC article. Review.
-
Anabolic androgenic steroid abuse in the United Kingdom: An update.Br J Pharmacol. 2020 May;177(10):2180-2198. doi: 10.1111/bph.14995. Epub 2020 Mar 3. Br J Pharmacol. 2020. PMID: 31989581 Free PMC article. Review.
-
The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review.BMC Nephrol. 2019 May 31;20(1):198. doi: 10.1186/s12882-019-1384-0. BMC Nephrol. 2019. PMID: 31151420 Free PMC article.
-
The Case: Chronic Kidney Disease Unmasked by Single-Subject Research.Case Rep Nephrol Dial. 2018 May 16;8(2):90-97. doi: 10.1159/000489087. eCollection 2018 May-Aug. Case Rep Nephrol Dial. 2018. PMID: 29928644 Free PMC article.
References
-
- Lindstrom M, Nilsson AL, Katzman PL, et al. Use of anabolic-androgenic steroids among body builders–frequency and attitudes. Journal of Internal Medicine 1999;227:407–11 - PubMed